# In vitro gastrointestinal digestion simulation screening of novel ACEI peptides from broccoli: mechanism in high glucose-induced VSMCs dysfunction

**Authors:** Shuzhi Zhang, Jingjing Guo, Shikun Suo, Li Ju, Zhaoqiang Jiang, Pingshuan Dong, Yanli Wang, Yali Dang, Laijing Du

PMC · DOI: 10.3389/fnut.2025.1528184 · Frontiers in Nutrition · 2025-01-27

## TL;DR

This study identifies stable ACE-inhibitory peptides from broccoli that can reduce vascular smooth muscle cell dysfunction caused by high glucose.

## Contribution

The study identifies five novel ACEI peptides from broccoli with high stability and strong bioactivity in a high glucose-induced VSMCs model.

## Key findings

- ACEI activity of broccoli peptides increased by 70.73% after in vitro digestion.
- Five peptides (HLEVR, LTEVR, LEHGF, HLVNK, LLDGR) showed strong ACEI activity and high intestinal stability.
- The peptides reduced Ang II-induced VSMCs dysfunction by modulating ACE/ACE2 and MAPK pathways.

## Abstract

Many natural angiotensin-converting enzyme inhibitory (ACEI) peptides have been widely studied. However, their stability in vivo is poor in most cases. In this study, peptides were initially digested from broccoli in vitro, and absorption was simulated by Caco2 cells transport and then analyzed by Peptideomics and molecular docking. Subsequently, the mechanisms were verified using a high glucose-induced vascular smooth muscle cells (VSMCs) dysfunction model. Results showed that ACEI activity of broccoli crude peptide increased by 70.73 ± 1.42% after digestion. The enzymatic hydrolysates of crude broccoli peptides before and after digestion were detected by HPLC. The digested crude peptides were highly stable (with a stability level > 90%) in the intestine and possessed a strong absorptive potential. Five peptides with high stability and strong permeability were first identified, including HLEVR, LTEVR, LEHGF, HLVNK, and LLDGR, which exhibited high activity with IC50 values of 3.19 ± 0.23 mM, 17.07 ± 1.37 mM, 0.64 ± 0.02 mM, 0.06 ± 0.01 mM, and 2.81 ± 0.12 mM, respectively. When the VSMCs model was exposed to Ang II, the expressions of PCNA, MMP2, and Bcl2 were increased, while the expression of BAX was inhibited. When the VSMCs was exposed to high glucose (HG), the Ang II concentration significantly increased. This indicates that HG elevated Ang II levels. Finally, five peptides significantly attenuated Ang II-induced VSMCs proliferation and migration by down-regulating AT1R expression and inhibiting ERK and p38 MAPK phosphorylation. Notably, in exploring VSMCs dysfunction on a high glucose-induced model, ACEI peptides resulted in down-regulation of ACE and up-regulation of ACE2 expression. Therefore, it can be further referenced for the functional food against hypertension and cardiovascular diseases.

## Linked entities

- **Genes:** PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], AGTR1 (angiotensin II receptor type 1) [NCBI Gene 185], ACE (angiotensin I converting enzyme) [NCBI Gene 1636], ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272], EPHB2 (EPH receptor B2) [NCBI Gene 2048], P38mapk (p38 map kinase) [NCBI Gene 692545]
- **Chemicals:** Ang II (PubChem CID 172198)

## Full-text entities

- **Genes:** AGTR1 (angiotensin II receptor type 1) [NCBI Gene 185] {aka AG2S, AGTR1B, AT1, AT1AR, AT1B, AT1BR}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}
- **Diseases:** cardiovascular diseases (MESH:D002318), hypertension (MESH:D006973), VSMCs (MESH:D018235)
- **Chemicals:** glucose (MESH:D005947)
- **Species:** Brassica oleracea var. italica (asparagus broccoli, varietas) [taxon 36774]
- **Cell lines:** Caco2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11807808/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11807808/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC11807808/full.md

---
Source: https://tomesphere.com/paper/PMC11807808